论文部分内容阅读
慢性乙肝患者临床证侯错综复杂,如何抓住病变本质,从关键病机入手组方用药,是提高临床疗效的重要途径。益肝康冲剂属七五国家攻关课题研究成果之一,是从长期临床运用中筛选出来的有效方剂。已有实验证明,该冲剂具有抗乙肝病毒,抗急性肝损伤,调节免疫功能等作用。本实验主要观察了益肝康冲剂阻止复合因素所致大鼠肝硬变形成的作用。1 材料和方法1.1 实验动物 SD大白鼠(鄂医动物管证号012)70只,雌雄各半,体重160g左右,随机分成5组,每组14只,即A组(正常对照组)、B组(病理对照组)、C组(乙
The complexity of clinical syndromes in patients with chronic hepatitis B, how to seize the essence of the disease, start from the key pathogenesis group prescription drugs, is an important way to improve clinical efficacy. Yigankang Granules is one of the research achievements of the national research projects in the seven-five years and is an effective formula selected from long-term clinical applications. Experiments have shown that the granules have anti-hepatitis B virus, anti-acute liver injury, regulate immune function and so on. This experiment mainly observed the effect of Yigankang Granules on preventing liver cirrhosis caused by compound factors in rats. 1 Materials and methods 1.1 Experimental animals SD rats (Erhua Animal Identification Number 012) 70 males and females, weighing about 160g, were randomly divided into 5 groups, each group of 14, ie, group A (normal control group), B Group (Pathology Control Group), Group C (B